{"id":10379,"date":"2026-11-09T11:48:05","date_gmt":"2026-11-09T11:48:05","guid":{"rendered":"https:\/\/godshand.link\/ground_post\/global-leishmaniasis-surveillance-updates-2025\/"},"modified":"2026-11-09T11:48:05","modified_gmt":"2026-11-09T11:48:05","slug":"global-leishmaniasis-surveillance-updates-2025","status":"publish","type":"ground_post","link":"http:\/\/godshand.link\/en_gb\/ground_post\/global-leishmaniasis-surveillance-updates-2025\/","title":{"rendered":"Global leishmaniasis surveillance updates 2025"},"content":{"rendered":"<p><br \/>\n<\/p>\n<section class=\"dynamic-content__section dynamic-content__container\">\n<div class=\"dynamic-content__section-container\">\n<div class=\"dynamic-content__figure-container\">\n<figure class=\"dynamic-content__figure\">\n      <img decoding=\"async\" src=\"https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/dc6c34cd-2f0b-493f-8b7a-4b5f41b7d7ed\/content\" alt=\"Global leishmaniasis surveillance updates 2025\"><br \/>\n     <\/figure>\n<div class=\"button button-blue-background\"><a target=\"_blank\" href=\"https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/ec4ca811-3029-4308-9502-bcd3e79b6724\/content\" onclick=\"sendGaEvent('Download','https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/ec4ca811-3029-4308-9502-bcd3e79b6724\/content')\">Download <span>(4.6 MB)<\/span><\/a><\/div><\/div>\n<div class=\"dynamic-content__description-container\">\n<div class=\"row\">\n<div class=\"col-md-8\">\n<div class=\"dynamic-content__description\">\n<h3>Overview <\/h3>\n<p>This report on global leishmaniasis surveillance follows those published in 2016\u20132025. Six leishmaniasis indicators are publicly available from the Global Health Observatory (GHO). Country profiles with up to 30 indicators are also published, using detailed data received from 45 Member States.<\/p>\n<p>This report updates the GHO leishmaniasis indicators reported by Member States to WHO through 2025. It describes age<br \/>\nand gender distribution, relapse, visceral leishmaniasis (VL) case fatality rates (CFRs) and the burden of post-kala-azar dermal<br \/>\nleishmaniasis (PKDL). It also covers treatment regimens and outcomes for VL, HIV\u2013VL coinfection, the kala-azar elimination<br \/>\nprogramme in South-East Asia and the VL elimination initiative in eastern Africa. Updates on animal reservoir control interventions in the Americas and WHO-facilitated supplies of quality-assured health products are also included.<\/p>\n<p>\u00a0<\/p>\n<\/p><\/div><\/div>\n<div class=\"col-md-4\">\n<div class=\"dynamic-content__details\">\n<div class=\"detail who-team\">\n<div class=\"label\">WHO Team<\/div>\n<div class=\"value\">\n                 <span><br \/>\nMalaria and Neglected Tropical Diseases (MNT)                 <\/span>\n         <\/div><\/div>\n<div class=\"detail\">\n<div class=\"label\">Editors<\/div>\n<div class=\"value\">World Health Organization<\/div><\/div>\n<div class=\"detail\">\n<div class=\"label\">Number of pages<\/div>\n<div class=\"value\">13<\/div><\/div>\n<div class=\"detail\">\n<div class=\"label\">Reference numbers<\/div>\n<div class=\"value\">\n<div><strong class=\"label-sm\">WHO Reference Number: <\/strong><span>WER No. 44, 2026, 101, 331\u2013343<\/span><\/div><\/div><\/div>\n<div class=\"detail\">\n<div class=\"label\">Copyright<\/div>\n<p>                <a target=\"_blank\" class=\"creativecommons-icons-wrappers\" href=\"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/igo\/deed.en\" rel=\"license\" title=\"Click here to see the details of CC BY-NC-SA 3.0 IGO\"><br \/>\n                        <img decoding=\"async\" src=\"https:\/\/www.who.int\/ResourcePackages\/WHO\/assets\/icons\/cc-icons\/cc.svg\"><br \/>\n                        <img decoding=\"async\" src=\"https:\/\/www.who.int\/ResourcePackages\/WHO\/assets\/icons\/cc-icons\/by.svg\"><br \/>\n                        <img decoding=\"async\" src=\"https:\/\/www.who.int\/ResourcePackages\/WHO\/assets\/icons\/cc-icons\/nc.svg\"><br \/>\n                        <img decoding=\"async\" src=\"https:\/\/www.who.int\/ResourcePackages\/WHO\/assets\/icons\/cc-icons\/sa.svg\"><br \/>\n                <\/a>\n        <\/div><\/div><\/div><\/div><\/div><\/div>\n<\/section>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.who.int\/publications\/i\/item\/who-wer10144-331-343?rand=6398\" target=\"_blank\">Source link <\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Download (4.6 MB) Overview This report on global leishmaniasis surveillance follows those published in 2016\u20132025. Six leishmaniasis indicators are publicly available from the Global Health Observatory (GHO). Country profiles with up to 30 indicators are also published, using detailed data received from 45 Member States. This report updates the GHO leishmaniasis indicators reported by Member States to WHO through 2025.&hellip;<\/p>","protected":false},"author":99035,"featured_media":10380,"parent":0,"menu_order":0,"comment_status":"open","ping_status":"open","template":"","format":"standard","meta":{"give_campaign_id":0,"footnotes":""},"tags":[455,3065,511,438],"ground_category":[315,316],"class_list":["post-10379","ground_post","type-ground_post","status-publish","format-standard","has-post-thumbnail","hentry","tag-global","tag-leishmaniasis","tag-surveillance","tag-updates","ground_category-2-grounds-tribulation","ground_category-2-1-time-disease"],"fifu_image_url":"https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/dc6c34cd-2f0b-493f-8b7a-4b5f41b7d7ed\/content","_links":{"self":[{"href":"http:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/ground_post\/10379","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/ground_post"}],"about":[{"href":"http:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/types\/ground_post"}],"author":[{"embeddable":true,"href":"http:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/users\/99035"}],"replies":[{"embeddable":true,"href":"http:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/comments?post=10379"}],"version-history":[{"count":0,"href":"http:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/ground_post\/10379\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/media\/10380"}],"wp:attachment":[{"href":"http:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/media?parent=10379"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/tags?post=10379"},{"taxonomy":"ground_category","embeddable":true,"href":"http:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/ground_category?post=10379"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}